Investors in Health

Seroba is a leading European life sciences venture capital firm, dedicated to creating value by supporting innovative biotech and medtech companies. With a focus on breakthrough technologies, Seroba has backed significant advancements such as Shorla Oncology's FDA-approved TEPYLUTE, a ready-to-dilute formulation for treating breast and ovarian cancer. Based in Dublin, Seroba leverages deep industry expertise to help entrepreneurs build world-class businesses, fostering extraordinary scientific innovations.

Digital transformation is rapidly reshaping global industries such as healthcare, logistics, and agriculture, extending its reach even to remote regions. The democratization of capital facilitated by Covid-19 has opened up global investment opportunities for companies worldwide, from Nigeria to Romania. Concurrently, there has been a significant rise in online commerce, facilitating cross-border trade and increasing product diversity. With a solid foundation in traditional business and the establishment of a leading digital media group, the firm is highly regarded as a partner for innovative companies in Bulgaria and beyond. They strategically diversify investments between individual companies and funds to mitigate risks effectively. Notable investments include eBag in groceries ecommerce, BIODIT in biometric security, and Superdoc & Healee in telemedicine, highlighting their commitment to leveraging expertise and market access for substantial business growth.

Neo Ventures is a deep tech fund that invests in the builders of digital infrastructure for smart cities, outpatient healthcare, and space missions. For nearly a decade, they have supported artificial intelligence and machine learning technology startups in developing and deploying reliable, scalable data solutions that serve billions today. Neo Ventures provides comprehensive support to founders, including business planning, scaling operations, follow-on investments, maximizing opportunities, and navigating challenging situations.

Eleven is one of the leading early-stage VCs in Southeast Europe, investing in startups since 2012. With 170+ collective investments over 12 years, Eleven’s team has been instrumental in catalyzing the regional startup ecosystem. Eleven supports tech companies in four priority verticals - Fintech, Healthcare, Future of Work, and Sustainable Food. Some of the startups that Eleven has backed include Payhawk, Quantive, Dronamics, SMSBump, and Native Teams.

Oscar & Paul operates as a corporate venture capital firm of Beiersdorf.At O&P Beiersdorf Venture Capital, we are dedicated to shaping the future of skin care by creating innovative solutions that enhance people's well-being in their skin. Through collaboration with startups and corporations.

DHP Capital is an investment firm that invests in digital healthcare venture cases. We are deeply rooted in the healthcare industry with a strong international network. DHP Capital is a stage-agnostic investor with an exclusive focus on Healthcare Technology companies. We invest in businesses with best-in-class technologies and aim to scale them into digital leaders.

Bayer Open Innovation's global innovation networks service offering enables clients to design, build and optimize innovation on a global scale through the creation of innovation networks that combine R&D, market intelligence, and local talent and resources.

SCOR Ventures is a closely integrated part of SCOR’s L&H and P&C business units that invests in and partners with early stage Insurtech companies. SCOR Ventures forms collaborative, long-term partnerships with digital-first insurers, MGAs and distributors, software solutions that benefit SCOR and/or our clients, and companies that help people live healthier lives, in support of industry innovation and SCOR’s Global business. Combining the Art and Science of Risk to protect societies.

In 2016, Fundis, regional development company InnovationQuarter and Noaber Foundation started the FundIQare incubator fund. The fund focuses on start-ups that provide innovative products and / or services that improve the quality of life of frail elderly, chronically ill and caregivers. The care for these groups is under pressure due to the increase in the number of elderly people, the longer independent (wanting to) live and the changing welfare state with a retreating government. Through the collaboration, the parties are able to open up a large user group, finance and professionalize companies so that they are able to scale up nationally.

Hitachi Ventures is the global venture capital arm of Hitachi Group, a global industrial player active in a broad range of technology sectors. Hitachi Ventures invests in innovative companies that address society’s key technological, social and environmental challenges in areas like IT, industrial automation (robotics, sensor technology and IoT). Hitachi intends to leverage its strong position in multiple global technology markets, its expertise and network to support and promote Hitachi Ventures portfolio companies.

The Bupa eco-Disruptive Challenge and how we collaborate with start-ups to find innovative sustainability solutions.Bupa is a global healthcare company committed to improving lives and creating a better world. Serving over 38 million customers in 190 countries, Bupa reinvests profits to enhance healthcare services and employs 85,000 people worldwide.

Founded in 2001, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.